Joseph R. Cohen
Amgen (United States)(US)
Publications by Year
Research Areas
Cancer Cells and Metastasis, Immunotherapy and Immune Responses, Genetic factors in colorectal cancer, TGF-β signaling in diseases, Hedgehog Signaling Pathway Studies
Most-Cited Works
- → Anxiety and Depression During Childhood and Adolescence: Testing Theoretical Models of Continuity and Discontinuity(2017)108 cited
- → The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies(2013)81 cited
- → An Autocrine Loop between TGF-β1 and the Transcription Factor Brachyury Controls the Transition of Human Carcinoma Cells into a Mesenchymal Phenotype(2013)61 cited
- → Disruption of the PACAP gene promotes medulloblastoma in ptc1 mutant mice(2007)47 cited
- → Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures(2010)40 cited
- → Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy(2022)24 cited
- → Does change in perceptions of peer teen dating violence predict change in teen dating violence perpetration over time?(2017)23 cited
- → Emerging Adulthood and Prospective Depression: A Simultaneous Test of Cumulative Risk Theories(2019)22 cited
- → PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression(2023)21 cited
- → A High Threshold of Biotherapeutic Aggregate Numbers is Needed to Induce an Immunogenic Response In Vitro, In Vivo, and in the Clinic(2024)15 cited